FTDI
MLAB icon

First Trust Direct Indexing’s Mesa Laboratories MLAB Stock Holding History

First Trust Direct Indexing’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-154
Closed -$44K – 746
2020
Q4 		$44K Buy
+154
New +$42.4K 0.01% 782

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

First Trust Direct Indexing's MLAB Position: Q1 2021 in Review

First Trust Direct Indexing sold out of Mesa Laboratories (MLAB) in Q1 2021, closing a stake of 154 shares — an estimated $44K sold.

First Trust Direct Indexing first reported a position in MLAB in Q4 2020 and held it in 1 quarter. The position peaked at $44K in Q4 2020. 173 funds tracked by Wall St. Rank hold MLAB as of Q1 2021.

  • First Trust Direct Indexing reported no remaining Mesa Laboratories position as of Q1 2021 after selling out during the quarter.
  • First Trust Direct Indexing sold 154 Mesa Laboratories shares in Q1 2021, an estimated $44K.
  • First Trust Direct Indexing first reported a position in Mesa Laboratories in Q4 2020 and held it in 1 quarter.
  • First Trust Direct Indexing's Mesa Laboratories position peaked at $44K in Q4 2020.
  • 173 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2021.

Based on First Trust Direct Indexing's 13F filing for Q1 2021, filed 14 Apr 2021.